Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Central Nervous System Neoplasms × Lapatinib × Clear all

Sponsor

Conditions

Breast Neoplasms 62 Neoplasms 13 Neoplasm Metastasis 6 Breast Neoplasms, Male 6 Brain Neoplasms 6 Head and Neck Neoplasms 5 Ovarian Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Pancreatic Neoplasms 2 Osteitis Deformans 2 Neuroma, Acoustic 2 Neurofibromatosis 2 2 Inflammatory Breast Neoplasms 2 Esophageal Neoplasms 2 Ependymoma 2 Colorectal Neoplasms 2 Carcinoma, Squamous Cell 2 Carcinoma, Ovarian Epithelial 2 Carcinoma, Intraductal, Noninfiltrating 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thymoma 1 Spinal Cord Neoplasms 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Salivary Gland Neoplasms 1 Recurrence 1

Interventions

Temozolomide 28 Radiotherapy 20 Bevacizumab 9 Carboplatin 8 Radiation 6 Filgrastim 6 Etoposide 6 Magnetic Resonance Spectroscopy 5 Irinotecan 5 Cyclophosphamide 5 etoposide phosphate 4 Vincristine 4 Ifosfamide 4 Granulocyte Colony-Stimulating Factor 4 Everolimus 4 X-Rays 3 Thalidomide 3 Specimen Handling 3 Phantoms, Imaging 3 Lomustine 3 Cisplatin 3 Chemotherapy, Adjuvant 3 Celecoxib 3 vitespin 2 poly ICLC 2 larotrectinib 2 Thiotepa 2 Rituximab 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy, Conformal 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡